Free Consultation Request
* denotes required fields
I agree to the KTMC disclaimer
I would like to receive new case alerts by email

Investigation of Potential Action on Behalf of Diplomat Pharmacy, Inc. (Nasdaq: DPLO)

Kessler Topaz Meltzer & Check, LLP is investigating a potential shareholder action on behalf of current shareholders of Diplomat Pharmacy, Inc. (“Diplomat”).

About Diplomat Pharmacy, Inc.

Diplomat operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems..

Alleged Wrongful Conduct

Kessler Topaz Meltzer & Check, LLP is investigating potential breaches of fiduciary duties by members of Diplomat’s Board of Directors, which may have caused harm to the company and its shareholders.

If you currently own shares of Diplomat Pharmacy, Inc. (Nasdaq: DPLO) and would like to learn more about our investigation, please fill out our online form or contact us today at 888-299-7706 or info@ktmc.com.